ValGenesis Announces Strategic Reseller Partnership with Validator K.K. to Expand in the Japanese Market
July 02 2024 - 9:00AM
Business Wire
ValGenesis, Inc., the market leader in enterprise validation
lifecycle management systems (VLMS), and Validator K.K., a reputed
Japanese validation products and services company, have entered
into a strategic reseller partnership that leverages Validator’s
unique on-site validation services model for the Japanese life
sciences sector.
Established in 2015, Validator is recognized for its commitment
to quality and continuous improvement, as evidenced by its ISO9001
certification. The company’s unique business model, featuring
on-site validation services, has been well-received by companies
that find it challenging to secure in-house validation staff, have
high travel costs, or require equipment that needs expertise and
cannot be entrusted to other companies.
ValGenesis is the industry innovator of digitized validation.
The company’s platform, which includes its flagship VLMS offering,
is used in over 100,000 GMP systems worldwide, helping life
sciences companies advance their digital transformation strategy,
enforce compliance, and enable standardization with 100% digital,
risk-based validation software.
Validator’s services solve a range of key issues within the
pharmaceutical industry, making them a go-to partner in Japanese
life sciences. As a ValGenesis reseller partner in Japan, customers
can leverage Validator’s on-site services model alongside
ValGenesis VLMS, the industry standard digital validation
platform.
This unique service model presents exclusive benefits to
Validator customers, including on-demand expertise with flexible
scaling up or down based on customer needs, comprehensive risk
management and risk mitigation through the team’s extensive service
experience, increased budget flexibility, and more importantly,
improved quality assurance.
“With Japan being the world’s second-largest pharma and medtech
market and a key innovation center for the global life sciences
industry, ValGenesis is honored to enter this market through a
reliable partner, like Validator,” says Bo Olsen, ValGenesis’ SVP
of Partners. “Through Validator’s on-site service model, customers
can now access world-class smart solutions, like ValGenesis VLMS,
that supports digital transformation and brings value to each step
of a company’s validation and manufacturing processes. Our
partnership with Validator presents the ideal approach to
digitization that is adapted specifically to the country’s and
industry’s conditions.”
“We eagerly look forward to this unique collaboration with
ValGenesis, a leading enterprise in validation lifecycle management
systems. Paper-based validation is still common in Japan, however
with the recent updates regarding GMP audits, paper-based
validation management is reaching its limits. We are honored to
build this partnership in response to customer and government
requirements through ValGenesis VLMS,” says Tamura Hiroki,
Representative Director of Validator K.K., Japan. “Japan’s top
ranking in the global pharmaceutical market is supported by
tireless R&D and quality control efforts. With Japan's current
shrinking population and labor shortage, productivity improvements
are inevitable. Digital transformation is necessary to accelerate
adaptation with sustainable growth.”
ABOUT VALIDATOR
Established in 2015, Validator K.K. is a Japanese company
specializing in providing validation services to the life sciences
sector in Japan. The company’s core business includes the
development and sales of validation tools, as well as offering
validation consulting. The company’s unique business model that
focuses on on-site validation services is particularly beneficial
for companies that find it challenging to secure in-house
validation staff, have high travel costs, or require equipment that
needs expertise and cannot be entrusted to other companies.
Validator K.K. is also ISO9001 certified, demonstrating their
commitment to quality and continuous improvement. The company’s
services are designed to solve a range of problems, making them a
reliable partner in the life sciences industry. For more
information, visit https://validator.co.jp/en/.
ABOUT VALGENESIS, INC.
ValGenesis, Inc. is the creator of an innovative software
platform that serves as a foundation for managing compliance-based
validation activities in life science companies. ValGenesis, Inc.
is the provider of the first enterprise application that manages
the corporate validation lifecycle process. This solution is fully
compliant with U.S. FDA 21 CFR Part 11 and Annex 11 requirements.
As the first fully paperless solution for electronic management of
validation execution and approval, ValGenesis was selected by an
industry peer review committee to receive the Parenteral Drug
Association (PDA) New Innovative Technology Award in 2005. For more
information, visit https://www.valgenesis.com/.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240702720241/en/
Althea D’Sylva, ValGenesis Communications, +1 510-445-0505 Ex.
1026, althea.dsylva@valgenesis.com
Nguyen Thi Thanh Van, Validator Business Development,
+81-44-280-6255, van.ntt@validator.co.jp